Details about Tomas Philipson

E-mail:
Homepage:	http://harrisschool.uchicago.edu/faculty/web-pages/tomas-philipson.asp
Workplace:	Harris School of Public Policy, University of Chicago, (more information at EDIRC) National Bureau of Economic Research (NBER), (more information at EDIRC) Manhattan Institute, (more information at EDIRC) American Enterprise Institute, (more information at EDIRC)

Access statistics for papers by Tomas Philipson.

Last updated 2010-01-17. Update your information in the RePEc Author Service.

Short-id: pph37

---

Jump to Journal Articles Chapters

Working Papers

2017

1. Sharing R&D Risk in Healthcare via FDA Hedges
   NBER Working Papers, National Bureau of Economic Research, Inc

2016

2. How Does Technological Change Affect Quality-Adjusted Prices in Health Care? Systematic Evidence from Thousands of Innovations
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)

2014

3. Financial Health Economics
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (2)
4. Health Care Adherence and Personalized Medicine
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (4)

2013

5. Adjusting National Accounting for Health: Is the Business Cycle Countercyclical?
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)
6. Economic Analysis of Risk and Uncertainty induced by Health Shocks: A Review and Extension
   NBER Working Papers, National Bureau of Economic Research, Inc
7. International Health Economics
   NBER Working Papers, National Bureau of Economic Research, Inc

2012

8. Public Liabilities and Health Care Policy
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)

2011

9. Can Medical Progress be Sustained? Implications of the Link Between Development and Output Markets
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (10)

2010

10. Terminal Care and The Value of Life Near Its End
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (8)
11. The Impact of Comparative Effectiveness Research on Health and Health Care Spending
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (6)

2009

12. An Economic Evaluation of the War on Cancer
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (5)
13. Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (20)
14. The Effects of Product Liability Exemption in the Presence of the FDA
    NBER Working Papers, National Bureau of Economic Research, Inc
    See also Chapter (2010)

2008

15. Is the Obesity Epidemic a Public Health Problem? A Decade of Research on the Economics of Obesity
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (32)
16. The Value of Life in General Equilibrium
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (7)

2007

17. Integrated Insurance Design in the Presence of Multiple Medical Technologies
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (27)
    See also Journal Article in American Economic Review (2007)
18. Is the Food and Drug Administration Safe and Effective?
    NBER Working Papers, National Bureau of Economic Research, Inc
    See also Journal Article in Journal of Economic Perspectives (2008)
19. The Value of Life Near its End and Terminal Care
    Levine's Working Paper Archive, David K. Levine View citations (10)
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (2007) View citations (9)

2006

20. Antitrust in the Not-For-Profit Sector
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (8)
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (2001) View citations (6)
    See also Journal Article in Journal of Law and Economics (2009)
21. Health Care, Technological Change, and Altruistic Consumption Externalities
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (3)
22. Intellectual Property and Marketing
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (9)
23. Surplus Appropriation from R&D and Health Care Technology Assessment Procedures
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (9)
    Also in Public Economics, University Library of Munich, Germany (2005) View citations (2)

2005

24. Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (2)
25. Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (4)
    See also Journal Article in Forum for Health Economics & Policy (2006)

2004

26. Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (4)
    See also Chapter (2005)
    Journal Article in Forum for Health Economics & Policy (2005)

2003

27. Intellectual Property & External Consumption Effects: Generalizations from Pharmaceutical Markets
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (10)
28. The Quantity and Quality of Life and the Evolution of World Inequality
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (35)
    See also Journal Article in American Economic Review (2005)

2002

29. The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (15)
30. The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the US
    Working Papers, Harris School of Public Policy Studies, University of Chicago
31. The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination
    Working Papers, Harris School of Public Policy Studies, University of Chicago View citations (17)
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (2002) View citations (203)

2000

32. External Treatment Effects and Program Implementation Bias
    NBER Technical Working Papers, National Bureau of Economic Research, Inc View citations (11)
    Also in Working Papers, Harris School of Public Policy Studies, University of Chicago (1999)
33. Merit Motives and Government Intervention: Public Finance in Reverse
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (7)
    Also in University of Chicago - Population Research Center, Chicago - Population Research Center View citations (4)

1999

34. Aging and the Growth of Long-Term Care
    Working Papers, Harris School of Public Policy Studies, University of Chicago
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (1999) View citations (6)
35. Economic Epidemiology and Infectious Diseases
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (25)
    See also Chapter (2000)
36. The Long-Run Growth in Obesity as a Function of Technological Change
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (112)
    Also in Working Papers, Harris School of Public Policy Studies, University of Chicago (1999)

1998

37. Data MArkets and OPtimal Sample Size Determination
    DELTA Working Papers, DELTA (Ecole normale supérieure)
38. Nonprofit Production and Competition
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (31)
39. Pricing and R&D with Related Margins
    DELTA Working Papers, DELTA (Ecole normale supérieure)
40. The Rise in Old Age Longevity and the Market for Long-Term Care
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (5)
    Also in University of Chicago - George G. Stigler Center for Study of Economy and State, Chicago - Center for Study of Economy and State (1998) View citations (13)
    See also Journal Article in American Economic Review (2002)

1997

41. An Empirical Examination of Information Barriers to Trade inInsurance
    University of Chicago - George G. Stigler Center for Study of Economy and State, Chicago - Center for Study of Economy and State View citations (5)
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (1996) View citations (10)
    See also Journal Article in American Economic Review (1999)
42. Consumption vs. Production of Insurance
    NBER Working Papers, National Bureau of Economic Research, Inc
43. Health investment complementarities under competing risks
    Economics Working Papers, Department of Economics and Business, Universitat Pompeu Fabra View citations (2)
44. Observational Agency and Supply-Side Econometrics
    NBER Technical Working Papers, National Bureau of Economic Research, Inc
45. The Future of Old-Age Longevity: Competitive Pricing of Morality Contingent Claims
    University of Chicago - George G. Stigler Center for Study of Economy and State, Chicago - Center for Study of Economy and State View citations (3)
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (1997) View citations (3)

1996

46. Mortality Contingent Claims, Health Care, and Social Insurance
    University of Chicago - George G. Stigler Center for Study of Economy and State, Chicago - Center for Study of Economy and State View citations (4)
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (1996) View citations (1)
47. The Private Demand for Information and the Effects of Public Testing Programs: The Case of HIV
    Working Papers, Yale - Economic Growth Center View citations (1)

1995

48. Death, Tetanus and Aerobics: The Evaluation of Disease-Specific Health Interventions
    CEPR Discussion Papers, C.E.P.R. Discussion Papers
    Also in Economics Working Papers, Department of Economics and Business, Universitat Pompeu Fabra (1995)
49. Disease Complementarities and the Evaluation of Public Health Interventions
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)
50. Disease Eradication: Private vs. Public Vaccination
    DELTA Working Papers, DELTA (Ecole normale supérieure) View citations (1)
51. Rational Epidemics and their Public Control
    DELTA Working Papers, DELTA (Ecole normale supérieure)
    See also Journal Article in International Economic Review (1996)

1994

52. Will the AIDS Epidemic be Self-Limiting? Evidence on the Responsiveness of the Demand for Condoms to the Prevalence of AIDS
    Working Papers, Harris School of Public Policy Studies, University of Chicago
    Also in University of Chicago - Population Research Center, Chicago - Population Research Center View citations (3)

Undated

53. Estimating the Extent of Trade Under Incomplete Information: The Case of HIV
    University of Chicago - Population Research Center, Chicago - Population Research Center
54. Is Health Care Technology Over-Approved? A Meta-Analysis of Revealed Preference
    University of Chicago - Population Research Center, Chicago - Population Research Center
55. Nonprofit Production
    University of Chicago - Population Research Center, Chicago - Population Research Center View citations (7)
56. Self-Interested Treatment Evaluation in Experiments
    University of Chicago - Population Research Center, Chicago - Population Research Center

Journal Articles

2009

1. Antitrust in the Not-for-Profit Sector
   Journal of Law and Economics, 2009, 52, (1), 1-18 View citations (18)
   See also Working Paper (2006)
2. `Me-Too' Innovation in Pharmaceutical Markets
   Forum for Health Economics & Policy, 2009, 12, (1), 1-21 View citations (5)
   See also Chapter (2009)

2008

3. Cost-benefit analysis of the FDA: The case of the prescription drug user fee acts
   Journal of Public Economics, 2008, 92, (5-6), 1306-1325 View citations (7)
4. Cost-effectiveness analysis and innovation
   Journal of Health Economics, 2008, 27, (5), 1224-1236 View citations (23)
5. Is the Food And Drug Administration Safe And Effective?
   Journal of Economic Perspectives, 2008, 22, (1), 85-102 View citations (9)
   See also Working Paper (2007)
6. Is the Obesity Epidemic a Public Health Problem? A Review of Zoltan J. Acs and Alan Lyles's Obesity, Business and Public Policy
   Journal of Economic Literature, 2008, 46, (4), 974-82 View citations (24)

2007

7. Integrated Insurance Design in the Presence of Multiple Medical Technologies
   American Economic Review, 2007, 97, (2), 427-432 View citations (29)
   See also Working Paper (2007)
8. Labor Supply and Weight
   Journal of Human Resources, 2007, 42, (1) View citations (48)
9. The institute of medicine report on the FDA: where is the science?
   Health Economics, 2007, 16, (3), 219-221

2006

10. The nonprofit sector and industry performance
    Journal of Public Economics, 2006, 90, (8-9), 1681-1698 View citations (91)
11. Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs
    Forum for Health Economics & Policy, 2006, 9, (2), 1-33 View citations (20)
    See also Working Paper (2005)

2005

12. Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
    Forum for Health Economics & Policy, 2005, 8, (1), 1-25
    See also Chapter (2005)
    Working Paper (2004)
13. The Quantity and Quality of Life and the Evolution of World Inequality
    American Economic Review, 2005, 95, (1), 277-291 View citations (335)
    See also Working Paper (2003)
14. Welfare-Enhancing Technological Change and the Growth of Obesity
    American Economic Review, 2005, 95, (2), 253-257 View citations (115)

2002

15. Pricing and R&D When Consumption Affects Longevity
    RAND Journal of Economics, 2002, 33, (1), 85-95
16. The Rise in Old-Age Longevity and the Market for Long-Term Care
    American Economic Review, 2002, 92, (1), 295-306 View citations (46)
    See also Working Paper (1998)

2001

17. Data Markets, Missing Data, and Incentive Pay
    Econometrica, 2001, 69, (4), 1099-1111 View citations (11)
18. Managed Care and the Quality of Health Care: A Misguided Debate?
    The Journal of Legal Studies, 2001, 30, (2), 753-58
19. Public Financing and the Market for Long-Term Care
    Forum for Health Economics & Policy, 2001, 4, (1), 1-19
    See also Chapter (2001)
20. The world-wide growth in obesity: an economic research agenda
    Health Economics, 2001, 10, (1), 1-7 View citations (82)

1999

21. An Empirical Examination of Information Barriers to Trade in Insurance
    American Economic Review, 1999, 89, (4), 827-846 View citations (162)
    See also Working Paper (1997)
22. Longevity Complementarities under Competing Risks
    American Economic Review, 1999, 89, (5), 1358-1371 View citations (48)
23. Measurement errors: A principal investigator-agent approach
    Journal of Econometrics, 1999, 91, (2), 273-298 View citations (11)

1998

24. Old-Age Longevity and Mortality-Contingent Claims
    Journal of Political Economy, 1998, 106, (3), 551-573 View citations (101)
25. Subject Evaluation in Social Experiments
    Econometrica, 1998, 66, (2), 381-408 View citations (11)

1997

26. Disease Eradication: Private versus Public Vaccination
    American Economic Review, 1997, 87, (1), 222-30 View citations (69)
27. Multiple-output agency incentives in data production: experimental evidence
    European Economic Review, 1997, 41, (3-5), 961-970
28. The evaluation of new health care technology: The labor economics of statistics
    Journal of Econometrics, 1997, 76, (1-2), 375-395 View citations (4)

1996

29. An empirical examination of the implications of assortative matching on the incidence of HIV
    Journal of Health Economics, 1996, 15, (6), 735-749 View citations (3)
30. Equilibrium and Efficiency in an Organized Vote Market
    Public Choice, 1996, 89, (3-4), 245-65 View citations (25)
31. Rational Epidemics and Their Public Control
    International Economic Review, 1996, 37, (3), 603-24 View citations (64)
    See also Working Paper (1995)
32. The Economic Epidemiology of Crime
    Journal of Law and Economics, 1996, 39, (2), 405-33 View citations (25)

1995

33. The welfare loss of disease and the theory of taxation
    Journal of Health Economics, 1995, 14, (3), 387-395 View citations (7)

1994

34. Public Spending on AIDS Education: An Economic Analysis
    Journal of Law and Economics, 1994, 37, (1), 17-38 View citations (9)

1993

35. Social Welfare and Measurement of Segregation
    Journal of Economic Theory, 1993, 60, (2), 322-334 View citations (9)

1991

36. Dynamic information release
    Journal of Economics, 1991, 53, (2), 205-213

Chapters

2018

1. The Economic Value and Pricing of Personalized Medicine
   A chapter in Economic Dimensions of Personalized and Precision Medicine, 2018, pp 9-19

2010

2. The Effects of Product Liability Exemption in the Presence of the FDA
   A chapter in Regulation vs. Litigation: Perspectives from Economics and Law, 2010, pp 137-163 View citations (3)
   See also Working Paper (2009)

2009

3. "Me-Too" Innovation in Pharmaceutical Markets
   A chapter in Frontiers in Health Policy Research, volume 12, 2009 View citations (3)
   See also Journal Article in Forum for Health Economics & Policy (2009)

2005

4. Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
   A chapter in Frontiers in Health Policy Research, Volume 8, 2005
   See also Working Paper (2004)
   Journal Article in Forum for Health Economics & Policy (2005)

2003

5. Theories of Firm Behavior in the Nonprofit Sector. A Synthesis and Empirical Evaluation
   A chapter in The Governance of Not-for-Profit Organizations, 2003, pp 181-216 View citations (33)

2001

6. Medical Care Output and Productivity in the Nonprofit Sector
   A chapter in Medical Care Output and Productivity, 2001, pp 119-140 View citations (1)
7. Public Financing and the Market for Long-Term Care
   A chapter in Frontiers in Health Policy Research, Volume 4, 2001, pp 77-94
   See also Journal Article in Forum for Health Economics & Policy (2001)

2000

8. Asymmetric Information and the Not-for-Profit Sector Does Its Output Sell a a Premium?
   A chapter in The Changing Hospital Industry: Comparing Not-for-Profit and For-Profit Institutions, 2000, pp 325-356 View citations (3)
9. Economic epidemiology and infectious diseases
   Chapter 33 in Handbook of Health Economics, 2000, vol. 1, pp 1761-1799 View citations (49)
   See also Working Paper (1999)